Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal

被引：1
|
作者：
Aratake, Junichi [1 ]
Suzuki, Eiji [1 ]
Uehiro, Natsue [1 ]
Nishie, Mariko [1 ]
Kawaguchi, Kosuke [1 ]
Sato, Fumiaki [1 ]
Toi, Masakazu [1 ]
机构：
[1] Kyoto Univ Hosp, Kyoto 606, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1092
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Src family kinases and HER2 interactions in human breast cancer cell growth and survival
    Belsches-Jablonski, AP
    Biscardi, JS
    Peavy, DR
    Tice, DA
    Romney, DA
    Parsons, SJ
    ONCOGENE, 2001, 20 (12) : 1465 - 1475
  • [32] Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
    Suzuki, Eiji
    Kataoka, Tatsuki R.
    Hirata, Masahiro
    Kawaguchi, Kosuke
    Nishie, Mariko
    Haga, Hironori
    Toi, Masakazu
    BMC CANCER, 2015, 15
  • [33] Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
    Eiji Suzuki
    Tatsuki R Kataoka
    Masahiro Hirata
    Kosuke Kawaguchi
    Mariko Nishie
    Hironori Haga
    Masakazu Toi
    BMC Cancer, 15
  • [34] Treatment options in ErbB2 (HER2)-overexpressing breast cancer
    Jackisch, Christian
    BREAST CARE, 2008, 3 : 1 - 1
  • [35] HER2 gene amplification in HER2 2+breast cancer and its clinicopathological characteristics
    Wan, Dan
    Wang, Xi
    Zhang, Yu -Tao
    ASIAN JOURNAL OF SURGERY, 2023, 46 (02) : 1097 - 1098
  • [36] Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status
    Ray, Amitabha
    Nkhata, Katai J.
    Cleary, Margot P.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (06) : 1499 - 1509
  • [37] Sensitivity to the HER2 tyrosine kinase inhibitor lapatinib in breast cancer cells overexpressing truncated HER2 receptor (P95HER-2)
    Scaltriti, Maurizio
    Di Cosimo, Serena
    Ocana, Alberto
    Guzman, Marta
    Cortes, Javier
    Rojo, Federico
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 58 - 58
  • [38] Biology of HER2 and its importance in breast cancer
    Yarden, Y
    ONCOLOGY, 2001, 61 : 1 - 13
  • [39] Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
    Arriola, Edurne
    Marchio, Caterina
    Tan, David Sp
    Drury, Suzanne C.
    Lambros, Maryou B.
    Natrajan, Rachael
    Rodriguez-Pinilla, Socorro Maria
    Mackay, Alan
    Tamber, Narinder
    Fenwick, Kerry
    Jones, Chris
    Dowsett, Mitch
    Ashworth, Alan
    Reis-Filho, Jorge S.
    LABORATORY INVESTIGATION, 2008, 88 (05) : 491 - 503
  • [40] Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
    Taskar, Kunal S.
    Rudraraju, Vinay
    Mittapalli, Rajendar K.
    Samala, Ramakrishna
    Thorsheim, Helen R.
    Lockman, Julie
    Gril, Brunilde
    Hua, Emily
    Palmieri, Diane
    Polli, Joseph W.
    Castellino, Stephen
    Rubin, Stephen D.
    Lockman, Paul R.
    Steeg, Patricia S.
    Smith, Quentin R.
    PHARMACEUTICAL RESEARCH, 2012, 29 (03) : 770 - 781
12345